Guggenheim Capital’s Verastem VSTM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q2
– Sell
-913
Closed -$33K – 2616
2018
Q1
$33K Sell
913
-20
-2% -$775 ﹤0.01% 2723
2017
Q4
$34K Sell
933
-116
-11% -$5.24K ﹤0.01% 2651
2017
Q3
$59K Sell
1,049
-18
-2% -$849 ﹤0.01% 2691
2017
Q2
$28K Hold
1,067
– – ﹤0.01% 2767
2017
Q1
$27K Buy
+1,067
New +$16.9K ﹤0.01% 2760
2016
Q2
– Sell
-851
Closed -$16K – 2934
2016
Q1
$16K Buy
+851
New +$13.7K ﹤0.01% 2842
2015
Q4
– Sell
-20,328
Closed -$437K – 3085
2015
Q3
$437K Buy
+20,328
New +$1.61M ﹤0.01% 2466

Other funds holding VSTM

Guggenheim Capital's VSTM Position: Q2 2018 in Review

Guggenheim Capital sold out of Verastem (VSTM) in Q2 2018, closing a stake of 913 shares — an estimated $33K sold.

Guggenheim Capital first reported a position in VSTM in Q3 2015 and held it in 7 quarters. The position peaked at $437K in Q3 2015. 102 funds tracked by Wall St. Rank hold VSTM as of Q2 2018.

  • Guggenheim Capital reported no remaining Verastem position as of Q2 2018 after selling out during the quarter.
  • Guggenheim Capital sold 913 Verastem shares in Q2 2018, an estimated $33K.
  • Guggenheim Capital first reported a position in Verastem in Q3 2015 and held it in 7 quarters.
  • Guggenheim Capital's Verastem position peaked at $437K in Q3 2015.
  • 102 funds tracked by Wall St. Rank held Verastem as of Q2 2018.

Based on Guggenheim Capital's 13F filing for Q2 2018, filed 14 Aug 2018.